+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer



Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer



Acta Oncologica 43(4): 396-403



There is evidence that tumor hypoxia adversely affects loco-regional tumor control and survival in head and neck cancer. The aim of the current study was to compare pretreatment tumor oxygenation measured by Eppendorf pO2 electrodes with known prognostic factors in advanced head and neck tumors after definitive radiotherapy, and to evaluate the prognostic significance of these parameters on loco-regional tumor control. Sixty-seven patients, median age 56 years (22-82), all with primary stage III-IV squamous cell carcinoma were available for survival analysis. Tumor oxygenation was described as the fraction of pO2 values < or = 2.5 mmHg (HP2.5) and the median tumor pO2. By regression analysis HP2.5 was independent of known prognostic factors including stage, pretreatment hemoglobin (Hb) and the largest tumor diameter at the site of pO2 measurement. By Kaplan-Meier analysis loco-regional tumor control at 5 years was in favor of less hypoxic tumors using either HP2.5 or median tumor pO2 as descriptors and stratifying by the median values. Also, Hb was prognostic of loco-regional tumor control at 5 years using the median value as cut off. HP2.5 as continuous parameter was highly significant for loco-regional tumor control in a multivariate analysis. In conclusion both HP2.5 and total Hb were prognostic for loco-regional tumor control, but HP2.5 as continuous variable was independently the strongest prognostic indicator for loco-regional tumor control after definitive primary radiotherapy in advanced head and neck tumors.

(PDF emailed within 0-6 h: $19.90)

Accession: 012713616

Download citation: RISBibTeXText

PMID: 15303502

DOI: 10.1080/02841860410026189


Related references

Po-0980: Primary tumor and lymph nodes Ct radiomics to predict loco-regional control in head and neck cancer. Radiotherapy and Oncology 127: S542-S543, 2018

Preliminary evidence of prognostic significance in loco-regional control of Tpot in head and neck tumors treated by primary radiotherapy. European Journal of Histochemistry 37(SUPPL 2): 57, 1993

Hypoxia in advanced head and neck Adverse effect on loco-regional tumour control, and survival after primary radiation therapy. Radiotherapy & Oncology 56(Supplement 1): S91, 2000

Hemoglobin levels in patients with advanced head and neck cancer do not correlate with tumor hypoxia. International Journal of Radiation Oncology Biology Physics 48(3 Supplement): 263-264, 2000

Parallel assessment of hypoxia in tumor and LN metastases increases prognostic value of hypoxia-specific PET imaging in locally advanced head-and-neck cancer secondary analysis of the DDFMISO trial. European Journal of Cancer 72: S102-S103, 2017

The effects of postoperative irradiation on loco-regional tumor control and survival in patients with head and neck carcinomas by tumor subsites and relative risk factors for recurrence. International Journal of Radiation Oncology Biology Physics 39(2 SUPPL ): 307, 1997

CT-based follow-up following radiotherapy or radiochemotherapy for locally advanced head and neck cancer; outcome and development of a prognostic model for regional control. British Journal of Radiology 89(1068): 20160492, 2016

Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiotherapy & Oncology 53(2): 119-125, 1999

Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. RadioTherapy and Oncology 53(2): 119-125, 2000

Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy. RadioTherapy and Oncology 116(1): 87-93, 2015

Extraordinary tumor control in phase I trial of concurrent tirapazamine cisplatin and radiotherapy for far advanced head and neck cancer. International Journal of Radiation Oncology Biology Physics 45(3 SUPPL ): 148-149, 1999

Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer. Southern New Jersey Head and Neck Cancer Treatment Group. American Journal of Surgery 174(5): 527-531, 1997

Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancer. Head and Neck 36(9): 1363-1367, 2015

A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiotherapy & Oncology 57(1): 39-43, 2000

Radiotherapy of early breast cancer. More than loco-regional tumor control. Magyar Onkologia 45(4): 361-371, 2002